Market research
WMD.V WeedMD Inc
V CAD Healthcare
Latest close
As of 05 Dec 2024
Test a moving-average rule with historical data.
Market facts
- Market cap
- 68M
- P/E ratio
- Not available
- Analyst target
- 0.45
- Dividend yield
- 0.0%
- Beta
- 1.47
Profile
Instrument facts
- Exchange
- V
- Currency
- CAD
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- ISIN
- CA2938611001
- Market cap
- 68M
- P/E ratio
- Not available
- Analyst target
- 0.45
- Dividend yield
- 0.0%
- Beta
- 1.47
About
About WeedMD Inc
WeedMD Inc. produces, distributes, and sells medical-grade cannabis in Canada. It offers dried cannabis, cannabis plants and seeds, cannabis oil, edibles, extracts and topicals, and others, as well as cannabis flower products. The company sells its products directly to medical patients and strategic relationships across the seniors' market, as well as through supply agreements with Shoppers Drug Mart and six provincial distribution agencies under the Color Cannabis, Saturday, Starseed, and WeedMD brand names. WeedMD Inc. is headquartered in Aylmer, Canada.
Research context
WeedMD Inc appears in PyInvesting’s TSX Venture Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- CAD
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Community
Investor discussion
1 comment
Sign in to join the WMD.V discussion.
5 years, 6 months ago
WeedMD Inc is currently in a long term downtrend where the price is trading 13.7% below its 200 day moving average.
From a valuation standpoint, the stock is 99.8% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 2.2.
WeedMD Inc's total revenue sank by 5.1% to $6M since the same quarter in the previous year.
Its net income has increased by 164.4% to $9M since the same quarter in the previous year.
Finally, its free cash flow grew by 40.1% to $-5M since the same quarter in the previous year.
Based on the above factors, WeedMD Inc gets an overall score of 3/5.